Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis

M Drolet, É Bénard, N Pérez, M Brisson, H Ali, MC Boily… - The Lancet, 2019 - thelancet.com
Background More than 10 years have elapsed since human papillomavirus (HPV)
vaccination was implemented. We did a systematic review and meta-analysis of the …

Ten years of human papillomavirus vaccination in the United States

LE Markowitz, J Gee, H Chesson, S Stokley - Academic pediatrics, 2018 - Elsevier
Since human papillomavirus (HPV) vaccine was first introduced for females in the United
States in 2006, vaccination policy has evolved as additional HPV vaccines were licensed …

Prevalence of human papillomavirus among females after vaccine introduction—National Health and Nutrition Examination Survey, United States, 2003–2014

SE Oliver, ER Unger, R Lewis… - The Journal of …, 2017 - academic.oup.com
Background Human papillomavirus (HPV) vaccine was recommended in 2006 for routine
vaccination of US females aged 11–12 years. Most vaccine used through 2014 was …

Human papillomavirus vaccine impact and effectiveness through 12 years after vaccine introduction in the United States, 2003 to 2018

HG Rosenblum, RM Lewis, JW Gargano… - Annals of internal …, 2022 - acpjournals.org
Background: Human papillomavirus (HPV) vaccination was introduced in 2006 for females
and in 2011 for males. Objective: To estimate vaccine impact and effectiveness against …

Population-based HPV vaccination programmes are safe and effective: 2017 update and the impetus for achieving better global coverage

JML Brotherton, PN Bloem - Best practice & research Clinical obstetrics & …, 2018 - Elsevier
Persistent oncogenic human papillomavirus (HPV) is the cause of cervical cancer, as well as
cancers of the anus, penis, vulva, vagina and oropharynx. There is good evidence that …

[HTML][HTML] Protocolo Brasileiro para Infecções Sexualmente Transmissíveis 2020: infecção pelo papilomavírus humano (HPV)

NS Carvalho, RJC Silva, IC Val… - … e Serviços de …, 2021 - SciELO Public Health
O artigo aborda a infecção pelo papilomavírus humano (human papillomavirus, HPV), tema
constitutivo do Protocolo Clínico e Diretrizes Terapêuticas para Atenção Integral às Pessoas …

Human papillomavirus vaccine effectiveness and herd protection in young women

C Spinner, L Ding, DI Bernstein, DR Brown… - …, 2019 - publications.aap.org
BACKGROUND: Clinical trials of the 4-valent human papillomavirus (HPV) vaccine
demonstrate high efficacy, but surveillance studies are essential to examine the long-term …

Real-world impact and effectiveness of the quadrivalent HPV vaccine: an updated systematic literature review

W Wang, S Kothari, J Skufca, AR Giuliano… - Expert Review of …, 2022 - Taylor & Francis
Introduction Human papillomavirus (HPV) infection, which poses significant disease burden,
is decreasing following implementation of vaccination programs. Synthesized evidence on …

US health care clinicians' knowledge, attitudes, and practices regarding human papillomavirus vaccination: a qualitative systematic review

BL Rosen, A Shepard, JA Kahn - Academic pediatrics, 2018 - Elsevier
Clinicians' recommendation for the human papillomavirus (HPV) vaccine appears to be an
important driver of parental decisions about vaccination. Our aim was to synthesize the best …

Final analysis of a study assessing genital human papillomavirus genoprevalence in young Australian women, following eight years of a national vaccination program

SM Garland, AM Cornall, JML Brotherton, JD Wark… - Vaccine, 2018 - Elsevier
Abstract Objectives The VACCINE [Vaccine Against Cervical Cancer Impact and
Effectiveness] study evaluated the prevalence of quadrivalent vaccine-targeted human …